Lataa...
TNF inhibitor therapy for rheumatoid arthritis
Immunotherapy has markedly improved treatment outcomes in rheumatoid arthritis (RA). Tumor necrosis factor (TNF)-α antagonists, such as infliximab (IFX), etanercept (ETN), adalimumab (ADA), golimumab (GOLI) and certolizumab pegol (CZP) have been widely used for the treatment of RA. IFX provides sign...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
D.A. Spandidos
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3956207/ https://ncbi.nlm.nih.gov/pubmed/24648915 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/br.2012.42 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|